BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 19925564)

  • 1. Snail and Cox-2 expressions are associated with WHO tumor grade and survival rate of patients with gliomas.
    Myung J; Cho BK; Kim YS; Park SH
    Neuropathology; 2010 Jun; 30(3):224-31. PubMed ID: 19925564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overall survival in patients with malignant glioma may be significantly longer with tumors located in deep grey matter.
    Ramnarayan R; Dodd S; Das K; Heidecke V; Rainov NG
    J Neurol Sci; 2007 Sep; 260(1-2):49-56. PubMed ID: 17475281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
    Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
    Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in human gliomas is associated with unfavorable overall survival.
    Ding L; Sun X; You Y; Liu N; Fu Z
    Transl Res; 2010 Jul; 156(1):45-52. PubMed ID: 20621036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stratifin expression is a novel prognostic factor in human gliomas.
    Deng J; Gao G; Wang L; Wang T; Yu J; Zhao Z
    Pathol Res Pract; 2011 Nov; 207(11):674-9. PubMed ID: 21940111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases.
    Pollack IF; Claassen D; al-Shboul Q; Janosky JE; Deutsch M
    J Neurosurg; 1995 Apr; 82(4):536-47. PubMed ID: 7897512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
    Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone H1.0--a potential molecular marker with prognostic value for patients with malignant gliomas.
    Gabrovsky N; Georgieva M; Laleva M; Uzunov K; Miloshev G
    Acta Neurochir (Wien); 2013 Aug; 155(8):1437-42. PubMed ID: 23812966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA topoisomerase IIalpha predicts progression-free and overall survival in pediatric malignant non-brainstem gliomas.
    Bredel M; Pollack IF; Hamilton RL; Birner P; Hainfellner JA; Zentner J
    Int J Cancer; 2002 Jun; 99(6):817-20. PubMed ID: 12115482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
    Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
    Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
    He J; Deng Y; Yang G; Xie W
    J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic fibroblast growth factor expression as a predictor of prognosis in pediatric high-grade gliomas.
    Bredel M; Pollack IF; Campbell JW; Hamilton RL
    Clin Cancer Res; 1997 Nov; 3(11):2157-64. PubMed ID: 9815610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study.
    Krishnatry R; Zhukova N; Guerreiro Stucklin AS; Pole JD; Mistry M; Fried I; Ramaswamy V; Bartels U; Huang A; Laperriere N; Dirks P; Nathan PC; Greenberg M; Malkin D; Hawkins C; Bandopadhayay P; Kieran MW; Manley PE; Bouffet E; Tabori U
    Cancer; 2016 Apr; 122(8):1261-9. PubMed ID: 26970559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance.
    Hara A; Okayasu I
    Acta Neuropathol; 2004 Jul; 108(1):43-8. PubMed ID: 15088099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (1)H MRSI and progression-free survival in patients with WHO grades II and III gliomas.
    Hattingen E; Delic O; Franz K; Pilatus U; Raab P; Lanfermann H; Gerlach R
    Neurol Res; 2010 Jul; 32(6):593-602. PubMed ID: 19726017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between E-CD and Snail expressions and tumor invasion, metastasis and prognosis in colorectal cancer].
    Zheng BA; Deng GL; Dong QJ; Zhao ZS; Deng YC
    Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):111-6. PubMed ID: 20403241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas.
    Ali-Osman F; Brunner JM; Kutluk TM; Hess K
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2253-61. PubMed ID: 9815622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of indoleamine 2,3-dioxygenase and correlation with pathological malignancy in gliomas.
    Mitsuka K; Kawataki T; Satoh E; Asahara T; Horikoshi T; Kinouchi H
    Neurosurgery; 2013 Jun; 72(6):1031-8; discussion 1038-9. PubMed ID: 23426156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945.
    Eisenstat DD; Pollack IF; Demers A; Sapp MV; Lambert P; Weisfeld-Adams JD; Burger PC; Gilles F; Davis RL; Packer R; Boyett JM; Finlay JL
    J Neurooncol; 2015 Feb; 121(3):573-81. PubMed ID: 25431150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma.
    Ma J; Lang B; Wang X; Wang L; Dong Y; Hu H
    J Clin Neurosci; 2014 Nov; 21(11):1885-90. PubMed ID: 25001988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.